Breaking
Medicus Pharma Ltd. to Present at Biotech Showcase 2026, Advancing SkinJect ProgramEli Lilly's Legal Victory Over Noom's GLP-1 ClaimsBBSW AI Solution Event: Daily Roundup
Friday, June 19, 2026
🇺🇸 FDA

Autoimmune Diseases Analysis

🇺🇸 FDA

Expert commentary and market intelligence for pharma strategy teams

Showing 1–4 of 4 articles

High impact AnalysisJun 5, 2026

Otsuka kidney drug data and Pfizer AI deal: Biopharma deal tracker

IgA nephropathy · 8 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

Rallybio Pursues Reverse Merger with Avenzo Therapeutics to Advance Autoimmune Pipeline

autoimmune diseases · 7 min

Dr. Sarah Mitchell
High impact AnalysisApr 21, 2026

COFEPRIS Biocomparables Pathway: What You Need to Know

COFEPRIS · biosimilars · 4 min

Dr. Yuki Tanaka
Medium impact AnalysisApr 20, 2026

Biosimilar Competition Impact: US Biologics Market Analysis 2026

FDA · Oncology · 13 min

Dr. Sarah Mitchell

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.